Bessemer Group Inc Amphastar Pharmaceuticals, Inc. Transaction History

Bessemer Group Inc

$61.6 Billion
Q2 2025

A detailed history of Bessemer Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 200 shares of AMPH stock, worth $6,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Previous 561 64.35%

Holding current value

$6,070

Previous $17,000 70.59%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	SELL	$22.96 - $28.29 $8,288 - $10,212	-361 Reduced 64.35%	200 $5,000
Q1 2025 Apr 23, 2025	SELL	$26.24 - $38.48 $12.8 Million - $18.8 Million	-488,069 Reduced 99.89%	561 $17,000
Q4 2024 Feb 13, 2025	BUY	$36.84 - $53.4 $427,675 - $619,920	11,609 Added 2.43%	488,630 $18.1 Million
Q3 2024 Nov 12, 2024	BUY	$36.99 - $50.09 $399,233 - $540,621	10,793 Added 2.31%	477,021 $23.2 Million
Q2 2024 Aug 13, 2024	BUY	$38.65 - $43.48 $2.72 Million - $3.06 Million	70,287 Added 17.75%	466,228 $18.6 Million
Q1 2024 May 13, 2024	BUY	$42.85 - $63.45 $3 Million - $4.44 Million	69,968 Added 21.46%	395,941 $17.4 Million
Q4 2023 Feb 09, 2024	BUY	$44.49 - $62.93 $7.91 Million - $11.2 Million	177,829 Added 120.04%	325,973 $20.2 Million
Q3 2023 Nov 13, 2023	BUY	$45.51 - $65.0 $6.73 Million - $9.61 Million	147,824 Added 46195.0%	148,144 $6.81 Million
Q2 2023 Aug 10, 2023	BUY	$35.77 - $58.38 $6,510 - $10,625	182 Added 131.88%	320 $18,000
Q1 2023 May 10, 2023	BUY	$27.99 - $37.92 $671 - $910	24 Added 21.05%	138 $5,000
Q3 2022 Nov 09, 2022	SELL	$27.56 - $37.75 $1,322 - $1,812	-48 Reduced 29.63%	114 $3,000
Q1 2022 May 12, 2022	BUY	$22.96 - $36.45 $3,719 - $5,904	162 New	162 $6,000
Q3 2020 Nov 12, 2020	SELL	$17.99 - $22.22 $2.01 Million - $2.48 Million	-111,600 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$12.66 - $20.08 $11,394 - $18,072	900 Added 0.81%	111,600 $1.66 Million
Q4 2019 Feb 04, 2020	BUY	$17.07 - $20.64 $95,592 - $115,584	5,600 Added 5.33%	110,700 $2.14 Million
Q3 2019 Nov 07, 2019	BUY	$19.12 - $22.62 $126,192 - $149,292	6,600 Added 6.7%	105,100 $2.08 Million
Q2 2019 Jul 19, 2019	SELL	$18.92 - $22.96 $26,488 - $32,144	-1,400 Reduced 1.4%	98,500 $2.08 Million
Q1 2019 May 13, 2019	BUY	$19.46 - $25.28 $572,124 - $743,232	29,400 Added 41.7%	99,900 $2.04 Million
Q4 2018 Feb 12, 2019	BUY	$17.72 - $22.51 $678,676 - $862,133	38,300 Added 118.94%	70,500 $1.4 Million
Q3 2018 Nov 06, 2018	BUY	$15.39 - $19.38 $495,558 - $624,036	32,200 New	32,200 $620,000

Others Institutions Holding AMPH

# of Institutions

251

Shares Held

33.6M

Call Options Held

20.8K

Put Options Held

11.9K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.49B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Amphastar Pharmaceuticals, Inc. Transaction History